Medical - Devices · NASDAQ
当前价格
$164.23
内在价值
使用下方计算器估算
对 Align Technology, Inc. 运行完整的 DCF 分析,自动填充基本面数据,可调节假设参数,含敏感性热力图。
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
ROIC (TTM)
8.9%
ROE (TTM)
10.4%
FCF Yield
5.03%
基于过去 12 个月的数据,ALGN 每股自由现金流为 N/A,投入资本回报率(ROIC)为 8.9%,这些是使用 DCF 方法进行股票估值的关键输入。P/FCF 比率为 N/A,FCF 收益率为 5.03%,是评估 ALGN 相对估值的重要参考指标。
ALGN 的内在价值取决于对未来增长率、折现率(WACC)和终值的假设。使用 MiniValuator 免费 DCF 计算器,输入你自己的假设进行估算,并查看敏感性分析热力图。
ALGN 是否被低估取决于你的 DCF 假设。如果计算出的内在价值显著高于当前市价,则可能被低估。安全边际指示低估程度。在 MiniValuator 上运行完整估值来了解。
你可以使用 MiniValuator 的 DCF 计算器对 ALGN 估值:输入代码,查看自动填充的基本面数据,调整增长率和折现率假设,即可获得含敏感性热力图的即时内在价值。
DCF(折现现金流)估值通过将公司未来预期自由现金流折现回现值来估算内在价值。对于 ALGN,你输入预期增长率和折现率(WACC),模型会根据其未来现金产生能力计算股票当前应有的价值。
WACC(加权平均资本成本)是 ALGN 估值中使用的折现率。较高的 WACC 会降低内在价值估算,较低的 WACC 则会提高。使用 MiniValuator 的敏感性热力图查看不同 WACC 假设对 ALGN DCF 估值结果的影响。